ADVENZYMESBiotechnology
Advanced Enzyme Technologies Ltd — PE Ratio & Valuation Analysis
₹255.30
-3.13%
Current P/E23.70xPrice to earnings
Industry P/E51.82xSector average
4Y Avg P/E30.3x21.7% below avg
✅
54.3% Discount to Industry
ADVENZYMES P/E 23.70x vs sector avg 51.82x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹11.71 | ₹302 | 25.8x |
| 2024 | ₹11.92 | ₹348 | 29.2x |
| 2023 | ₹9.45 | ₹375 | 39.7x |
| 2022 | ₹10.68 | ₹281 | 26.3x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Advanced Enzyme Technologies Ltd Valuation
Advanced Enzyme Technologies Ltd (ADVENZYMES) currently trades at 23.70x earnings. The Biotechnology sector average PE is 51.82x. ADVENZYMES is trading at a discount to peers — may indicate relative value. Historically, ADVENZYMES has traded at an average PE of 30.3x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
9.54%
Dividend Yield
1.66%
More on Advanced Enzyme Technologies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.